Small-molecule XIAP inhibitors enhance γ-irradiation-induced apoptosis in glioblastoma

Neoplasia

Volumn 11, Issue 8, 2009, Pages 743-752

  Vellanki, Sri Hari Krishna ^a   Grabrucker, Andreas ^b   Liebau, Stefan ^b   Proepper, Christian ^b   Eramo, Adriana ^c   Braun, Veit ^d   Boeckers, Tobias ^b   Debatin, Klaus Michael ^a   Fulda, Simone ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d Ev Jung Stilling Krankenhaus   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; X LINKED INHIBITOR OF APOPTOSIS INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER STEM CELL; CELL SURVIVAL; CELL VIABILITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENZYME ACTIVATION; GAMMA IRRADIATION; GLIA CELL; GLIOBLASTOMA; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIZATION; RAT;

EID: 67650485853     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.09436     Document Type: Article

References (32)

1. DeAngelis LM (2001). Brain tumors. N Engl J Med 344, 114-123.
2. Stupp R, Hegi ME, Gilbert MR, and Chakravarti A (2007). Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 25, 4127-4136.
3. Chakravarti A and Palanichamy K (2008). Overcoming therapeutic resistance in malignant gliomas: current practices and future directions. Cancer Treat Res 139, 173-189.
4. Hengartner MO (2000). The biochemistry of apoptosis. Nature 407, 770-776.
5. Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, and Vandenabeele P (2004). Toxic proteins released from mitochondria in cell death. Oncogene 23, 2861-2874.
6. Kroemer G, Galluzzi L, and Brenner C (2007).Mitochondrial membrane permeabilization in cell death. Physiol Rev 87, 99-163.
7. Hanahan D and Weinberg RA (2000). The hallmarks of cancer. Cell 100, 57-70.
8. Fulda S and Debatin KM (2006). Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25, 4798-4811.
9. Fulda S (2009). Tumor resistance to apoptosis. Int J Cancer 124, 511-515.
10. LaCasse EC, Mahoney DJ, Cheung HH, Plenchette S, Baird S, and Korneluk RG (2008). IAP-targeted therapies for cancer. Oncogene 27, 6252-6275.
11. Fulda S, Wick W, Weller M, and Debatin KM (2002). Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8, 808-815.
12. Giagkousiklidis S, Vogler M, Westhoff MA, Kasperczyk H, Debatin KM, and Fulda S (2005). Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activator of caspase. Cancer Res 65, 10502-10513.
13. Giagkousiklidis S, Vellanki SH, Debatin KM, and Fulda S (2007). Sensitization of pancreatic carcinoma cells for gamma-irradiation-induced apoptosis by XIAP inhibition. Oncogene 26, 7006-7016.
14. Opel D, Westhoff MA, Bender A, Braun V, Debatin KM, and Fulda S (2008). Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis. Cancer Res 68, 6271-6280.
15. Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G, Pilozzi E, Larocca LM, Peschle C, and DeMaria R (2006). Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 13, 1238-1241.
16. Proepper C, Johannsen S, Liebau S, Dahl J, Vaida B, Bockmann J, Kreutz MR, Gundelfinger ED, and Boeckers TM (2007). Abelson interacting protein 1 (Abi-1) is essential for dendrite morphogenesis and synapse formation. EMBO J 26, 1397-1409.
17. Brito V, Beyer C, and Kuppers E (2004). BDNF-dependent stimulation of dopamine D5 receptor expression in developing striatal astrocytes involves PI3-kinase signaling. Glia 46, 284-295.
18. Oost TK, Sun C, Armstrong RC, Al-Assaad AS, Betz SF, Deckwerth TL, Ding H, Elmore SW, Meadows RP, Olejniczak ET, et al. (2004). Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer. J Med Chem 47, 4417-4426.
19. Fulda S, Sieverts H, Friesen C, Herr I, and Debatin KM (1997). The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 57, 3823-3829.
20. Mohr A, Zwacka RM, Debatin KM, and Stahnke K (2004). A novel method for the combined flow cytometric analysis of cell cycle and cytochrome c release. Cell Death Differ 11, 1153-1154.
21. Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, Diserens AC, and VanMeir EG (1999). Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 9, 469-479.
22. Fulda S, Scaffidi C, Pietsch T, Krammer PH, Peter ME, and Debatin KM (1998). Activation of the CD95 (APO-1/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells. Cell Death Differ 5, 884-893.
23. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, and Rich JN (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760.
24. Rich JN (2007). Cancer stem cells in radiation resistance. Cancer Res 67, 8980-8984.
25. Fulda S and Debatin KM (2004). Targeting apoptosis pathways in cancer therapy. Curr Cancer Drug Targets 4, 569-576.
26. Belka C, Jendrossek V, Pruschy M, Vink S, Verheij M, and Budach W (2004). Apoptosis-modulating agents in combination with radiotherapy-current status and outlook. Int J Radiat Oncol Biol Phys 58, 542-554.
27. Cao C, Mu Y, Hallahan DE, and Lu B (2004). XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer. Oncogene 23, 7047-7052.
28. Holcik M, Yeh C, Korneluk RG, and Chow T (2000). Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene 19, 4174-4177.
29. Karikari CA, Roy I, Tryggestad E, Feldmann G, Pinilla C, Welsh K, Reed JC, Armour EP,Wong J, Herman J, et al. (2007). Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein. Mol Cancer Ther 6, 957-966.
30. Fandy TE, Shankar S, and Srivastava RK (2008). Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells. Mol Cancer 7, 60.
31. Vucic D and Fairbrother WJ (2007). The inhibitor of apoptosis proteins as therapeutic targets in cancer. Clin Cancer Res 13, 5995-6000.
32. Bogler O and Weller M (2002). Apoptosis in gliomas, and its role in their current and future treatment. Front Biosci 7, e339-e353.